Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department
- PMID: 23331647
- DOI: 10.1016/j.annemergmed.2012.11.005
Clinical Policy: Use of intravenous tPA for the management of acute ischemic stroke in the emergency department
Abstract
This policy was developed by a joint writing panel of the American College of Emergency Physicians and the American Academy of Neurology. The panel reviewed the literature to derive evidence-based recommendations to help clinicians answer the following critical questions: (1) Is intravenous tissue plasminogen activator (tPA) safe and effective for acute ischemic stroke patients if given within 3 hours of symptom onset? (2) Is intravenous tPA safe and effective for acute ischemic stroke patients treated between 3 to 4.5 hours after symptom onset? Evidence was graded and recommendations were given based on the strength of the available data in the medical literature.
Comment in
-
The lytic lottery.Ann Emerg Med. 2013 Oct;62(4):432-3. doi: 10.1016/j.annemergmed.2013.03.038. Ann Emerg Med. 2013. PMID: 24054099 No abstract available.
-
In reply.Ann Emerg Med. 2013 Oct;62(4):433. doi: 10.1016/j.annemergmed.2013.04.015. Ann Emerg Med. 2013. PMID: 24054100 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
